Drug Sponsors

Novartis to sell influenza vaccines business to CSL for $275M

Monday, November 3, 2014 02:39 PM

Novartis has agreed to divest its influenza vaccines business to CSL for $275 million. This transaction requires regulatory approvals and is expected to close in the second half of 2015.

More... »


Five foundations to participate in Cavendish Global Health Impact Forum

Friday, October 31, 2014 02:18 PM

Cavendish Global has selected five foundations to participate in the Cavendish Global Health Impact Forum taking place Nov. 10-13 at Oxford University in the U.K. The selected organizations and the participating representatives include:

More... »

CenterWatch

Cytomedix re-brands as Nuo Therapeutics

Friday, October 31, 2014 02:05 PM

Cytomedix, a Gaithersburg, Md.-based pioneer in biodynamic therapies, has launched its new corporate brand identity, Nuo Therapeutics. The company intends to change its corporate name to Nuo Therapeutics, following shareholder approval of the name change proposal at its Annual General Meeting of the company's shareholders on Nov. 12.

More... »

Paratek Pharmaceuticals completes merger with Transcept Pharmaceuticals

Friday, October 31, 2014 02:04 PM

Boston-based Paratek Pharmaceuticals and Transcept Pharmaceuticals, based in California, have completed their merger. Transcept changed its name to Paratek Pharmaceuticals.

More... »

ReproCELL acquires Reinnervate and BioServe

Friday, October 31, 2014 01:54 PM

ReproCELL, a venture company in the iPS cell business originating from the University of Tokyo and Kyoto University, has acquired U.K.-based Reinnervate, a spin-out company from Durham University, a center of excellence in cell biology research, and BioServe Biotechnologies, based in Maryland, to accelerate its iPS cell business.

More... »

Abbott acquires medical device company Topera

Thursday, October 30, 2014 12:19 PM

Abbott has entered into an agreement to purchase Topera, a Menlo Park, Calif.-based, private, venture-backed medical device company focused on developing innovative electrophysiology technologies to improve the diagnosis and treatment of atrial fibrillation, one of the most common heart rhythm disorders in the world. Through this acquisition, Abbott enters the catheter-based electrophysiology market, an approximately $3 billion global market that has been growing annually at double-digit rates.

More... »

Sanofi board ousts CEO Viehbacher

Thursday, October 30, 2014 08:46 AM

By Ronald Rosenberg
CenterWatch Staff Writer

Paris-based biopharmaceutical company Sanofi ousted CEO Chris Viehbacher Wednesday, just two days after reporting disappointing quarterly earnings.

More... »

Wright Medical Group, Tornier to merge

Wednesday, October 29, 2014 01:29 PM

Wright Medical Group, a specialty orthopedic company that provides extremity and biologic solutions, and Tornier, a global medical device company, have entered a definitive merger agreement under which Wright and Tornier will combine in an all-stock transaction with a combined equity value of approximately $3.3 billion.

More... »

Amgen outlines strategy, will cut up to 4,000 jobs

Wednesday, October 29, 2014 01:28 PM

Amgen has outlined the company's strategy, growth objectives and capital allocation plans, and provided financial guidance for 2015. In addition to the approximately 2,900 positions already set to be eliminated by the end of 2015, an additional 600 to 1,100 jobs will be cut.

More... »

SRI International opens clinical trial unit in Michigan

Monday, October 27, 2014 01:04 PM

SRI Biosciences, a division of SRI International, a California-based independent nonprofit research institute, has completed construction of an early-phase clinical trial facility in Plymouth, Mich. The 9,400-square-foot unit, located in the Michigan Life Science Innovation Center, now is open and fully equipped for early-stage human research studies of new medicines and medical devices. 

More... »

Link to survey
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

December 15

Cancer Treatment Centers of America chooses WCG as its exclusive IRB, sheds five local hospital IRBs

Five southern research groups form public-private network to help save time, money for clients with early-stage biologics

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

December

Growing adoption of feasibility review committees
Early reports cite fewer amendments, improved cycle time

AMCs vying to better compete for industry trials
Working to conquer study start-up delays, IRB review process

Already a subscriber?
Log in to your digital subscription.

Purchase the October issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

November

Private equity driving dynamic CRO growth
Enables CROs to pursue long-term strategies, while giving the space credibility

Baby boomers poised to reshape clinical trials industry
Millions of tech-savvy consumers already track their health, expect new treatments as they age

Already a subscriber?
Log in to your digital subscription.

Purchase the September issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs